Pharmacodynamics and pharmacokinetics of budesonide: A new nebulized corticosteroid
Author:
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 104 (4) , S175-S183
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- AsthmaJAMA, 1997
- Molecular Mechanisms of Glucocorticoid Action in AsthmaPulmonary Pharmacology & Therapeutics, 1997
- Cytotoxicity of human phagocytes studiedin vitro in a novel model based on Neutral Red absorbtionInflammation Research, 1991
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991
- A study of the mechanism of the antiasthmatic action of inhaled budesonideJournal of Allergy and Clinical Immunology, 1990
- Bioequivalent doses of budesonide and prednisone in moderate and severe asthmaJournal of Allergy and Clinical Immunology, 1989
- Pulmonary disposition of the potent glucocorticoid budesonide, evaluated in an isolated perfused rat lung modelBiochemical Pharmacology, 1989
- Pharmacokinetics of budesonide in children with asthmaEuropean Journal of Clinical Pharmacology, 1987
- Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in manEuropean Journal of Clinical Pharmacology, 1982
- Influence of 16α,17α-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoidsThe Journal of Steroid Biochemistry and Molecular Biology, 1982